Eguchi, Shunsuke http://orcid.org/0000-0001-9512-1339
Morita, Yohei
Mitani, Hironobu
Kanegasaki, Ayako
Iwasaki, Kosuke
Yoshikawa, Tsutomu
Kitagawa, Hiroshi
Oyama, Naotsugu
Funding for this research was provided by:
Novartis Pharma K.K.
Article History
Accepted: 29 May 2022
First Online: 26 June 2022
Declarations
:
: This research was supported by Novartis Pharma K.K. The sponsor had a role in the conduct of the study; in the collection, analysis, and interpretation of data; in the writing of the report; and in the decision to submit the article for publication. Funding for the Open Access fee was provided by the sponsor.
: S.E., Y.M., H.M., H.K., and N.O. are employees of Novartis Pharma K.K. A.K. and K.I. are employees of Milliman, Inc. T.Y. has no conflict of interest to declare.
: This study was approved by the Ethics Review Committee of the nonprofit corporation Clinical Research Promotion Network Japan (protocol numbers: CLCZ696BJP01 and CLCZ696BJP02).
: The requirement of informed consent was waived given that the database protects patient anonymity.
: There was no requirement to obtain consent for publication given that the database protects patient anonymity.
: The individual deidentified participant data, study protocol, and statistical analysis plan will be shared upon reasonable requests made directly to the corresponding author (shunsuke.eguchi@novartis.com). The data requester should provide a methodologically sound proposal when making the request. The requested data will be available immediately and up to 1 year following the publication of this article.
: Not applicable.
: All authors contributed to all of the following: (1) study design, conduct, or collection; (2) data analysis and interpretation, (3) writing or reviewing the manuscript, and (4) final approval of the manuscript for submission.